Significance of desmoglein‐2 on cell malignant behaviors via mediating MAPK signaling in cervical cancer
Authors:
Open Access
- 13 January 2020
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 36 (5) , 336-343
Abstract
Desmoglein‐2 (DSG2) is an integral component of desmosomes, maintaining cell‐cell adhension in multiple cancers. It has been well studied in epithelial cells, cardiomyocytes and primary prostate cancer, colon cancer, skin squamous cell carcinoma, except for cervical cancer. Hence, we performed this study to examine the function of DSG2 in cervical cancer. We used TCGA and Oncomine databases to assess the expression level of DSG2 in cervical cancer cases. Kaplan‐Meier method with log‐rank test was utilized to plot overall survival (OS) curve. The reverse transcription‐quantitative polymerase chain reaction (qRT‐PCR) and western blotting were performed to detect the expression of DSG2 in cells. Cell Counting Kit‐8 (CCK‐8), wound‐healing analysis, and transwell assay were carried out to examine proliferation, migration, and invasion of cells. A higher level of DSG2 in cervical cancer was associated with lower OS rate. Knockdown of DSG2 inhibited cervical cancer cell proliferation, migration, and invasion, while DSG2 enhancement promoted cell proliferation, migration, and invasion. Moreover, the proteins expression of p‐MEK and p‐ERK that are required for mitogen‐activated protein kinases (MAPK) pathway were downregulated after reducing DSG2. In conclusion, these findings illustrated the importance of DSG2 in cervical cancer development and cell behaviors by mediating MAPK signaling pathway, suggesting DSG2 maybe a novel therapeutic target in control of cervical cancer.Keywords
This publication has 28 references indexed in Scilit:
- Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate CancerPLOS ONE, 2014
- Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signalingOncogene, 2013
- Structure, Function, and Regulation of Desmosomes2013
- DesmosomesCurrent Biology, 2011
- Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancerBMC Cancer, 2008
- Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinomaEuropean Journal of Cancer, 2006
- A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 2005
- Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolaeOncogene, 2004
- Tumor cell growth inhibition by caveolin re-expression in human breast cancer cellsOncogene, 1998
- Autophosphorylation sites on the epidermal growth factor receptorNature, 1984